This site is intended for health professionals only

At the heart of general practice since 1960

pulse june2020 80x101px
Read the latest issue online

GPs go forth

Pharmacists treating sore throats is not an 'innovation'

Letter from Dr Andrew Green, chair of the GPC clinical and prescribing subcommittee

Sore throats, you’d think we’d know how to treat them by now wouldn’t you? In truth I think we do. For many years we have encouraged patients to look upon an occasional sore throat as a small price to pay for the privilege of being alive. We’ve encouraged self-care, but accepted that we will see a few patients who don’t fit the usual picture, who do occasionally need attention for quinsy, glandular fever, or even the odd malignancy.

But now, under the smokescreen of NHS innovation, this is to change, with patients being encouraged not to self-care, but instead to attend a healthcare professional (a pharmacist) for testing and treatment. This has been based on a small study purporting to show that that antigen testing might reduce the need for antibiotics, but without asking the fundamental question, which is whether patients need treating even if they are carrying streptococci.

By encouraging attendance instead of self-care the actual number of antibiotics may increase rather than decrease, and by further reducing the confidence of the public in their ability to manage a simple self-limiting disease we do nobody any favours. Except perhaps the pharmacy chains who may be commissioned to provide this service. One of these, Boots, just happens to have funded the study in the first place. This potential conflict of interest should have sent people rushing to the evidence base, and if you do, you can find a larger study showing no additional benefit from antigen testing over a clinical assessment. 

Proving that a patient with a sore throat has bacteria present is very different from proving that they need treatment, and with antibiotics making no difference at day three to the majority of patients, and in wealthy societies not affecting complication rates, many GPs would prefer to follow the SIGN guidance which states that antibiotics should not be used to secure symptom relief for sore throats.

It is ironic in the extreme that this initiative has come at the start of self-care week. Perhaps what we really need in the NHS is more joined-up thinking, more application of existing knowledge, and a bit less innovation.

Rate this article  (5 average user rating)

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Readers' comments (3)

  • This is a very powerful article

    Even within our own firm where traditional pharma is very well trained at good clinical trials, there are some departments that deal with commissioners and talk about pilots studies or evaluation exercises.

    Its almost as if firms including my own and other vested interests have worked out by giving a scientific flavour to their sales pitch they can bypass EBM. Especially if deals are done with NHSE directly.

    We're seeing this with the roll out of web based GP services and pushing NOACS etc

    Its very dangerous and happening very quickly.

    Unsuitable or offensive? Report this comment

  • Pharmacists treating anybody without referring them directly to the GP 'urgently' would actually be an innovation

    Unsuitable or offensive? Report this comment

  • Sadly, Anonymous GP partner (17th Nov 3.35pm) we would love to treat much more than we currently can - the restrictions on treating eg eye infections with chloramphenicol or a patch of eczema on the face with hydrocortisone is nothing to do with us and everything to do with the licencing of otc meds which means they cannot be used in these cases. Changes to the licencing of these products would enable us to alleviate some of the workload GPs are struggling with and contribute to the re-education of patients around self-care

    Unsuitable or offensive? Report this comment

Have your say